<?xml version="1.0" encoding="utf-8"?><Section Number="0461.0134" xmlns="http://StatRev.xsd"><Catchline xml:space="preserve">Prescription or administration of dimethyl sulfoxide (DMSO); written release and information requirements.</Catchline><SectionBody><Subsection Id="1"><Text xml:space="preserve" Style="Intro">A podiatric physician licensed under this chapter may not be subject to disciplinary action by the board for prescribing or administering dimethyl sulfoxide (DMSO) to a patient under the podiatric physician’s care who has requested the substance as long as the podiatric physician complies with the requirements of this section.</Text></Subsection><Subsection Id="2"><Text xml:space="preserve" Style="Intro">The patient, after being fully informed as to alternative methods of treatment and their potential for cure and upon request for the administration of dimethyl sulfoxide (DMSO) by the patient’s podiatric physician, shall sign a written release, releasing the podiatric physician and, when applicable, the hospital or health facility from any liability therefor.</Text></Subsection><Subsection Id="3"><Text xml:space="preserve" Style="Intro">The podiatric physician shall inform the patient in writing if dimethyl sulfoxide (DMSO) has not been approved as a treatment or cure by the Food and Drug Administration of the United States Department of Health and Human Services for the disorder for which it is being prescribed.</Text></Subsection></SectionBody><History xml:space="preserve">ss. 5, 6, ch. 81-36; ss. 2, 3, 4, ch. 85-217; s. 13, ch. 86-71; s. 4, ch. 91-429; s. 224, ch. 97-103; s. 206, ch. 98-166.</History></Section>